Its stability in human gastric juice and potential oral bioactivity make it a rare peptide with possible systemic benefits even when taken non-injectably
Our combination therapy of (-)-Vestitol and Salviolone, identified via network medicine, targets multiple AD-related pathways, including Neuroactive ligand-receptor interaction and Calcium signaling pathway, potentially offering a more comprehensive, disease-modifying approach
With a molecular weight of approximately 340-400 Da (depending on counterions), the topical tripeptide copper complex readily penetrates the stratum corneum to interact with dermal fibroblasts
Studies in animal models have shown it may help protect and repair the lining of the stomach and intestines, with research exploring its effects on gastric ulcers, inflammatory bowel conditions, and intestinal tissue damage
Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies
Our earlier preview of the seven peptides under FDA review explains what each compound does and why it was nominated.
